Difference between revisions of "Team:Leicester/Description"

Line 1: Line 1:
 
{{Leicester}}
 
{{Leicester}}
<html>
+
<html lang="en">
 +
<body>
 +
   
 +
<div class="container" style="padding-bottom: 50px; padding-top:2px;">
 +
<div class="row">
 +
    <div class="col-sm-2" style="padding-left:0px; padding right:30px;"> 
 +
<ul class="nav nav-pills nav-stacked" style="margin-left:0px;">
 +
        <li class="active"><a href="#">Project</a></li>
 +
        <li><a href="#Int">Introduction</a></li>
 +
        <li><a href="#Col">Colonisation</a></li>
 +
        <li><a href="#kswitch">Kill Switch</a></li>
 +
        <li><a href="#NAD">NAD Transport</a></li>
 +
      </ul>
 +
    </div>
 +
    <div class="col-sm-8" style="color:#fff; background-color: #3498db; border-radius: 50px; border-top-right-radius: 0px; border-bottom-left-radius: 0px; padding-left:30px; padding-right:30px; padding-top:30px; padding-bottom:20px; box-shadow: 10px 10px 50px #000000;">
 +
        <h1>Leicester iGEM</h1>
 +
          <p>We will be updating this page as we go.</p>
  
<html>
+
<h2 id="Int"> Introduction </h2>
<style type="text/css">
+
  
p, #content {color:#000000;}
+
<p>Due to the allotted lab time for the iGEM project, and various other constraints this project would not go to completion. Knowing this in advance required important decisions to be made in the early phases of the project's design, meaning sections that would be theoretical and those that were feasible for a lab based approach had to be defined. At this point decisions were made that determined the overall direction of the project, with the most important factor being what was possible within the timescale all the while ensuring the parts that were created were those which were most associated with the fundamental aim of the project. This page describes the theoretical sections of the project, taking into consideration why they would be required, ethical implications for their use  as well as the steps and process that would have taken place to create them were the time available for a complete product. The reason as to why these particular components could not advance onto lab work stage will also be described.</P>
  
a, a:visited {color:#565656;}
 
  
body {background-color: #FFFFFF;}
 
  
#mainContainer {width: 980px;
+
<h2 id="Col"> Colonisation </h2>
overflow:hidden;
+
float:left;
+
margin-left:20px;
+
margin-bottom: 10px;
+
background-color: #E8E8E9;
+
border-bottom: 20px solid #14747D;}
+
  
#menuContainer  {float:left;
+
<h2 id=kswitch> Kill Switch </h2>
width: 150px;
+
padding: 20px 0px;
+
background-color: #22BCB9;
+
border-top: 20px solid #14747D;
+
font-family: "Lucida Sans Unicode", "Lucida Grande", sans-serif;}
+
  
#contentContainer {padding-top:20px;
+
<img src="https://static.igem.org/mediawiki/2015/2/2b/Kill_Switch_Fig1.jpg" align="right">
padding-right:10px;
+
<p>There are two kill switch systems in the genetically engineered bacteria: One, a kill switch which causes the bacteria to die upon addition of an inducer; the other, a maintenance kill switch whereupon the bacteria die if they leave the gut. This dual containment system allows for the reduction in bacterial escape and horizontal gene transfer as well as the death of the bacteria as a backup option if it goes wrong. </p>
margin-bottom: 20px;
+
<br>
width: 800px;
+
<p>Potentially could use a toxin-antitoxin system but with a modified antitoxin protein which incorporates a nonstandard amino acid that is vital for the toxin function. Therefore upon induction of the nonstandard amino acid the toxin will have the right amino acids needed for its correct synthesis and thus will kill the cell. It is easier and simpler than the altering 22 essential enzymes like Rovner et al, 2015 but more effective than toxin-antitoxin systems. However, this approach will need to add a stop codon for the nonstandard amino acid in a key hydrophobic region (if the nonstandard amino acid is hydrophobic) (Rovner et al, 2015) so that without the non-natural amino acid the protein cannot fold correctly and thus be subject to proteolysis. This results in cell death upon the addition of the non-standard amino acid. However this would require the changing of the stop codon used to another stop codon in all other genes as well as engineering a tRNA synthase that charges the non-natural amino acid to an edited tRNA molecule that is cognate for the stop codon used.</p>
padding-left: 20px;
+
<br>
float: left;
+
<p>The CCDA/CCDB kill switch is in an operon system with CCDA under the control of a temperature sensitive RBS (Part BBa_K115002) whereas the CCDB is under the control of a generic RBS (Part BBa_K581008). This means that at under 37<sup>O</sup>C (i.e. not in the human body) the translation rate  of the CCDA will dramatically decrease relative to other genes in the bacteria at the same temperature, whilst CCDB will remain the same in respect to the fundamental decrease in rate due to the lower temperature. Thus there will be a high enough ratio of CCDB (once translated) to kill the cell. Summed up: When the temperature is too cold, the antitoxin (CCDA) doesn’t work, so the toxin (CCDB) kills the cell.</p>
border-top: 20px solid #14747D;
+
<br>
background-color: #E8E8E9;
+
<p>However, CCDB is patented so another toxin/antitoxin system would be preferred such as MazF/MazE. If no antitoxin is available then the antitoxin in the system described above could be replaced with a polymerase gene (e.g. T7 Polymerase) and the desired toxin under the control of a promoter for that polymerase (i.e. a T7 consensus promoter). This would give higher levels of transcription and would be perhaps a more sure system. For our iGEM team however, due to time requirements, the simpler the system the better.</p>
font-family: "Lucida Sans Unicode", "Lucida Grande", sans-serif;
+
<br>
}
+
<p>Another Kill Switch which could be used to selectively kill the bacteria would be to use the X and Y expansion of the genetic code by Malyshev, et al 2014. This would use a toxin (Such as MazF toxin) that is dependent on the bases X and Y. This can be done by using long-range PCR for the MazF inside pUC19 but leaving a few bases in between the forward and the reverse primer. Then synthesis and PCR amplify an oligonucleotide which contains the primers and the X (dNaM)/Y (d5SICS) codon (Malyshev, et al 2014) for the non-natural amino acid for that codon (assuming there is a tRNA synthase for this). This can then be inserted into the PCR amplified pUC19 plasmid (with the gaps) through Gibson Assembly to then be transformed (Malyshev, et al 2014) as can be seen in figure 1. Proof will be needed for the incorporation of the X/Y through testing whether the transformed cells only die through addition of the X and/or Y base in a medium lacking these. This would significantly reduce the likelihood of the bacterium kill switch being activated naturally in the human microbiome. However, like through the addition of a nonstandard amino acid via stop codons, a tRNA molecule will be needed that can recognise the synthetic bases as well as a tRNA synthase which can accurately charge the nonstandard amino acid to this tRNA. As such this method can only be used in theory for our iGEM team. This will be a very useful application of synthetic biology once these key tRNA’s and tRNA synthases are ready. </p> 
  
#bannerContainer {
+
<h4> References: </h4>
height:200px;
+
margin:auto;
+
text-align:center;
+
color: #59BF92;
+
}
+
  
</style>
+
<ul>
 +
<li>Malyshev.D., Dhami, K., Lavergne, T., Chen, T., Dai,N., Foster,J., Correa,I. & Romesberg, F. 2014. A semi-synthetic organism with an expanded genetic alphabet. Nature 509 (7500) 385-388. </li>
 +
<br>
 +
<li>Rovner,A., Haimovich, A., Katz,S., Li, Z., Grome, M., Gassaway, B., Amiram,M., Patel,J., Gallagher,R., Rinehart,J. & Isaacs, F. 2015. Recoded organisms engineered to depend on synthetic amino acids. Nature, <b>518</b> (7537), 89-93. </li>
 +
</ul>
  
<h2> Project Description </h2>
+
<h2 id="NAD">NAD Transport</h2>
 
+
<p> We are The University of Leicester iGEM team. The first part of our project is generating genetically modified bacteria that can colonise the gut without disrupting the bacteria already there. We are proposing to do this by binding the bacteria to surface proteins that are on the bacteria that is already in the gut. </p>
+
+
<p> The second part of our project is to use this bacteria as a delivery system which contains an enzyme called NMNAT. This enzyme is part of the NAD+ pathway and so by increasing the concentration of NAD+ in the bacteria we should also increase NAD+ production. More NAD+ in the human body, according to some literature, aid in the treatment of neurodegenerative disorders like Parkinson's disease and Alzheimer's disease as well as helping to combat muscle fatigue. </p>
+
  
 +
    </div>
 +
    <div class="col-sm-2">
 +
        <a class="twitter-timeline" 
 +
data-widget-id="327381807010025474"
 +
href="https://twitter.com/iGEMLeicester"
 +
width="80"
 +
height="300">
 +
Tweets by @iGEMLeicester
 +
</a>
 +
<script>!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs"); </script>
 +
        </div>
 +
     
 +
    </div>
 +
   
 +
   
 +
    </div>   
 
</div>
 
</div>
 +
<p></p>
 +
</body>
 
</html>
 
</html>

Revision as of 21:04, 5 September 2015

Live Preview

Leicester iGEM

We will be updating this page as we go.

Introduction

Due to the allotted lab time for the iGEM project, and various other constraints this project would not go to completion. Knowing this in advance required important decisions to be made in the early phases of the project's design, meaning sections that would be theoretical and those that were feasible for a lab based approach had to be defined. At this point decisions were made that determined the overall direction of the project, with the most important factor being what was possible within the timescale all the while ensuring the parts that were created were those which were most associated with the fundamental aim of the project. This page describes the theoretical sections of the project, taking into consideration why they would be required, ethical implications for their use as well as the steps and process that would have taken place to create them were the time available for a complete product. The reason as to why these particular components could not advance onto lab work stage will also be described.

Colonisation

Kill Switch

There are two kill switch systems in the genetically engineered bacteria: One, a kill switch which causes the bacteria to die upon addition of an inducer; the other, a maintenance kill switch whereupon the bacteria die if they leave the gut. This dual containment system allows for the reduction in bacterial escape and horizontal gene transfer as well as the death of the bacteria as a backup option if it goes wrong.


Potentially could use a toxin-antitoxin system but with a modified antitoxin protein which incorporates a nonstandard amino acid that is vital for the toxin function. Therefore upon induction of the nonstandard amino acid the toxin will have the right amino acids needed for its correct synthesis and thus will kill the cell. It is easier and simpler than the altering 22 essential enzymes like Rovner et al, 2015 but more effective than toxin-antitoxin systems. However, this approach will need to add a stop codon for the nonstandard amino acid in a key hydrophobic region (if the nonstandard amino acid is hydrophobic) (Rovner et al, 2015) so that without the non-natural amino acid the protein cannot fold correctly and thus be subject to proteolysis. This results in cell death upon the addition of the non-standard amino acid. However this would require the changing of the stop codon used to another stop codon in all other genes as well as engineering a tRNA synthase that charges the non-natural amino acid to an edited tRNA molecule that is cognate for the stop codon used.


The CCDA/CCDB kill switch is in an operon system with CCDA under the control of a temperature sensitive RBS (Part BBa_K115002) whereas the CCDB is under the control of a generic RBS (Part BBa_K581008). This means that at under 37OC (i.e. not in the human body) the translation rate of the CCDA will dramatically decrease relative to other genes in the bacteria at the same temperature, whilst CCDB will remain the same in respect to the fundamental decrease in rate due to the lower temperature. Thus there will be a high enough ratio of CCDB (once translated) to kill the cell. Summed up: When the temperature is too cold, the antitoxin (CCDA) doesn’t work, so the toxin (CCDB) kills the cell.


However, CCDB is patented so another toxin/antitoxin system would be preferred such as MazF/MazE. If no antitoxin is available then the antitoxin in the system described above could be replaced with a polymerase gene (e.g. T7 Polymerase) and the desired toxin under the control of a promoter for that polymerase (i.e. a T7 consensus promoter). This would give higher levels of transcription and would be perhaps a more sure system. For our iGEM team however, due to time requirements, the simpler the system the better.


Another Kill Switch which could be used to selectively kill the bacteria would be to use the X and Y expansion of the genetic code by Malyshev, et al 2014. This would use a toxin (Such as MazF toxin) that is dependent on the bases X and Y. This can be done by using long-range PCR for the MazF inside pUC19 but leaving a few bases in between the forward and the reverse primer. Then synthesis and PCR amplify an oligonucleotide which contains the primers and the X (dNaM)/Y (d5SICS) codon (Malyshev, et al 2014) for the non-natural amino acid for that codon (assuming there is a tRNA synthase for this). This can then be inserted into the PCR amplified pUC19 plasmid (with the gaps) through Gibson Assembly to then be transformed (Malyshev, et al 2014) as can be seen in figure 1. Proof will be needed for the incorporation of the X/Y through testing whether the transformed cells only die through addition of the X and/or Y base in a medium lacking these. This would significantly reduce the likelihood of the bacterium kill switch being activated naturally in the human microbiome. However, like through the addition of a nonstandard amino acid via stop codons, a tRNA molecule will be needed that can recognise the synthetic bases as well as a tRNA synthase which can accurately charge the nonstandard amino acid to this tRNA. As such this method can only be used in theory for our iGEM team. This will be a very useful application of synthetic biology once these key tRNA’s and tRNA synthases are ready.

References:

  • Malyshev.D., Dhami, K., Lavergne, T., Chen, T., Dai,N., Foster,J., Correa,I. & Romesberg, F. 2014. A semi-synthetic organism with an expanded genetic alphabet. Nature 509 (7500) 385-388.

  • Rovner,A., Haimovich, A., Katz,S., Li, Z., Grome, M., Gassaway, B., Amiram,M., Patel,J., Gallagher,R., Rinehart,J. & Isaacs, F. 2015. Recoded organisms engineered to depend on synthetic amino acids. Nature, 518 (7537), 89-93.

NAD Transport